On the fly News and insights, exclusive to thefly.com

ACRS

Aclaris Therapeutics

$17.90 /

+0.17 (+0.96%)

, OTLY

Oatly Group

$27.30 /

-0.0901 (-0.33%)

09:54
06/15/21
06/15
09:54
06/15/21
09:54

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aclaris Therapeutics (ACRS) initiated with an Overweight at Piper Sandler. 2. Oatly Group (OTLY) initiated with a Hold at Nordea. 3. Myriad Genetics (MYGN) initiated with a Market Perform at Raymond James. 4. Exelixis (EXEL) initiated with a Buy at H.C. Wainwright. 5. Guardant Health (GH) initiated with a Market Perform at Raymond James. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ACRS

Aclaris Therapeutics

$17.90 /

+0.17 (+0.96%)

OTLY

Oatly Group

$27.30 /

-0.0901 (-0.33%)

MYGN

Myriad Genetics

$30.05 /

+0.12 (+0.40%)

EXEL

Exelixis

$23.00 /

+0.24 (+1.05%)

GH

Guardant Health

$122.27 /

-1.41 (-1.14%)

  • 15

    Jun

  • 16

    Jun

  • 07

    Oct

  • 20

    Jan

  • 20

    May

  • 10

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.